Dupuytrens Contracture
17
0
0
15
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
5.9%
1 terminated out of 17 trials
93.8%
+7.2% vs benchmark
53%
9 trials in Phase 3/4
47%
7 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (17)
Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture
AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Dupuytren's Contracture
Post Approval Commitment Study
Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures
A Pharmacokinetic Study of AA4500 (XIAFLEX™, Proposed Name) in Subjects With Dupuytren's Contracture
Administration of Two Injections for Multiple Dupuytren's Contractures
Collagenase Option for Reduction of Dupuytren's Contracture in Japan
Injectable Collagenase and Percutaneous Needle Fasciotomy for Dupuytren's Contracture
Prospective Randomized Trial Between Needle Fasciotomy and Xiapex for Dupuytrens Contracture
CORRECT: COmmunity RegistRy Study Evaluating Dupuytren's Contracture Treatment
Efficacy and Safety of Xiaflex Injection for Treatment of Dupuytren's Contracture of the Thumb
Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease
Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease
Treatment Of Dupuytren's Contracture With Collagenase Clostridium Histolyticum Injection (Xiapex)
Effects of Steroid Injection With Percutaneous Needle Aponeurotomy in Dupuytren's Contracture
Evaluation of the Efficiency of Autologous Platelet Gel (Platelet Rich Fibrin) Obtained From Own Patients' Blood Versus Vaselitulle in Dupuytren's Disease Postoperative Wound Healing
Health-Related Quality of Life in Patients With Dupuytren's Disease